Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, California, United States of America.
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, United States of America.
PLoS One. 2021 May 17;16(5):e0251684. doi: 10.1371/journal.pone.0251684. eCollection 2021.
ARHGAP36 is an atypical Rho GTPase-activating protein (GAP) family member that drives both spinal cord development and tumorigenesis, acting in part through an N-terminal motif that suppresses protein kinase A and activates Gli transcription factors. ARHGAP36 also contains isoform-specific N-terminal sequences, a central GAP-like module, and a unique C-terminal domain, and the functions of these regions remain unknown. Here we have mapped the ARHGAP36 structure-activity landscape using a deep sequencing-based mutagenesis screen and truncation mutant analyses. Using this approach, we have discovered several residues in the GAP homology domain that are essential for Gli activation and a role for the C-terminal domain in counteracting an N-terminal autoinhibitory motif that is present in certain ARHGAP36 isoforms. In addition, each of these sites modulates ARHGAP36 recruitment to the plasma membrane or primary cilium. Through comparative proteomics, we also have identified proteins that preferentially interact with active ARHGAP36, and we demonstrate that one binding partner, prolyl oligopeptidase-like protein, is a novel ARHGAP36 antagonist. Our work reveals multiple modes of ARHGAP36 regulation and establishes an experimental framework that can be applied towards other signaling proteins.
ARHGAP36 是一种非典型的 Rho GTPase 激活蛋白 (GAP) 家族成员,它既能驱动脊髓发育,又能促进肿瘤发生,其部分作用是通过抑制蛋白激酶 A 并激活 Gli 转录因子的 N 端基序。ARHGAP36 还含有同种型特异性的 N 端序列、中央 GAP 样模块和独特的 C 端结构域,这些区域的功能仍不清楚。在这里,我们使用基于深度测序的诱变筛选和截断突变体分析绘制了 ARHGAP36 的结构-活性图谱。通过这种方法,我们发现 GAP 同源结构域中的几个残基对于 Gli 激活是必需的,并且 C 端结构域在抵消某些 ARHGAP36 同种型中存在的 N 端自动抑制基序方面发挥作用。此外,这些位点中的每一个都调节 ARHGAP36 向质膜或初级纤毛的募集。通过比较蛋白质组学,我们还鉴定了与活性 ARHGAP36 优先相互作用的蛋白质,并且我们证明了一个结合伴侣,脯氨酰寡肽酶样蛋白,是一种新型的 ARHGAP36 拮抗剂。我们的工作揭示了 ARHGAP36 调节的多种模式,并建立了一个可应用于其他信号蛋白的实验框架。